Matrix Laboratories Limited

New Document

Financial Year 2007 - 2008

Quarter IV
(March 2008)

Quarter III
(December 2007)

Quarter II
(September 2007)

Quarter I
(June 2007)

Financial Year 2006 - 2007

Quarter IV
(March 2007)

Quarter III
(December 2006)

Quarter II
(September 2006)

Quarter I
(June 2006)

Financial Year 2005 - 2006

Quarter III
(December 2005)

Quarter II
(September 2005)

Quarter I
(June 2005)

Financial Year 2004 - 2005

Quarter IV
(March 2005)

Quarter III
(December 2004)

Quarter II
(September 2004)

Quarter I
(June 2004)

Financial Year 2003 - 2004

Quarter IV
(March 2004)

Quarter III
(December 2003)

Quarter II
(September 2003)

Quarter I
(June 2003)

Financial Year 2002 - 2003

Quarter IV
(March 2003)

Quarter III
(December 2002)

Quarter II
(September 2002)

Quarter I
(June 2002)

AUDITED FINANCIAL RESULTS
FOR
THE QUARTER ENDED 31ST DECEMBER 2003

(Rs.in Million )

Sl. No	Particulars	Quarter ended 31st December		Nine Months ended 31st December		Year Ended 31st March 2003 (Audited)
		2003 (Audited)	2002 ( Audited)	2003 (Audited)	2002 ( Audited)
	Gross Sales - Exports - Domestic	1441.99 755.84 686.15	787.42 653.16 134.26	4133.43 2258.94 1874.49	1897.49 1469.70 427.79	4169.27 2888.47 1280.80
1	Net Sales	1384.51	768.34	3959.83	1835.65	3990.30
2	Other Income	(1.81)	-	29.17	0.76	7.72
3	Total Expenditure a) (Increase) / Decrease in Stock b) Consumption of Raw materials c) Staff Cost d) Other Expenditure	927.37 (42.66) 614.30 54.96 300.77	412.37 54.01 196.07 14.01 148.28	2686.99 (262.52) 1983.21 152.67 813.63	987.95 59.23 551.86 41.84 335.02	2710.89 21.61 1672.08 142.24 874.96
4	Interest	19.19	14.43	63.81	34.50	260.39
5	Depreciation	31.97	6.02	81.19	18.33	71.96
6	Profit before Tax (1+2-3-4-5)	404.17	335.52	1157.01	795.63	954.78
7 8	Provision for Tax - Current - Deferred	40.00 30.00	15.50 11.86	115.00 80.00	28.00 15.50	57.00 147.24
9	Profit after Tax (6-7-8)	334.17	308.16	962.01	752.13	750.54
10	Equity Capital (fully paid up Rs. 10 each)	123.03	71.94	123.03	71.94	97.18
11	Share Capital suspense	-	-	-	-	25.79
12	Reserves excluding revaluation reserves	-	-	-	-	892.62
13	Basic E.P.S - Not Annualised (Rs.) - Annualised (Rs.) Diluted E.P.S - Not Annualised(Rs.) - Annualised (Rs.)	27.17 108.69 27.14 108.55	42.84 171.34 40.62 162.46	78.23 104.30 78.12 104.16	104.55 139.40 99.13 132.17	98.78 73.74
14	Aggregate of Non promoters Shareholding Number of shares Percentage of Shareholding	6585134 53.55%	4430164 61.64%	6585134 53.55%	4430164 61.64%	4430164 45.59%

Notes :

1. The Audited results for the year ended 31st March 2003 reflect the results of the amalgamated company.The figures for the corresponding quarter/ nine months in the previous year pertain only to that of Matrix Laboratories Limited and to that extent not comparable.

2. The above audited results were reviewed by the Audit Committee, considered and approved by the Board of Directors at their meeting held on 28th January 2004.

3. The activities of the Company relate to only one segment i.e. Pharmaceuticals.

4. The Board of Directors at their meetings held on 29th / 31st December 2003 have approved preferential issue of 22,50,000 equity shares of Rs.10/- each (aggregating to Rs.3375 Million) to India Newbridge Investments Ltd., and Maxwell (Mauritius) Pte Ltd.,

5. The Board of Directors have approved Interim Dividend of Rs.5/- per share and for this purpose fixed record date as 3rd February 2004.

6.Summary of Investor Complaints

Pending as
on 1.10.2003 Received during the
Quarter Resolved Pending as on
31.12.2003

Nil 11 11 Nil

	For and on behalf of the Board
Place : Secunderabad Date : 28th January 2004	Sd/- N.PRASAD Chairman & CEO

Foote Page